Baxter International Inc. (BAX)
| Market Cap | 9.58B |
| Revenue (ttm) | 11.02B |
| Net Income (ttm) | -341.00M |
| Shares Out | 514.06M |
| EPS (ttm) | -0.66 |
| PE Ratio | n/a |
| Forward PE | 8.48 |
| Dividend | $0.04 (0.21%) |
| Ex-Dividend Date | Nov 28, 2025 |
| Volume | 1,103,041 |
| Open | 18.38 |
| Previous Close | 18.26 |
| Day's Range | 18.25 - 18.67 |
| 52-Week Range | 17.40 - 37.74 |
| Beta | 0.61 |
| Analysts | Hold |
| Price Target | 25.67 (+37.72%) |
| Earnings Date | Oct 30, 2025 |
About BAX
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technolog... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 10 analysts, the average rating for BAX stock is "Hold." The 12-month stock price target is $25.67, which is an increase of 37.72% from the latest price.
News
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options
Baxter Presents Real-World Data at American Society of Health System Pharmacists Meeting Demonstrating Smart Infusion Pump Electronic Medical Record (EMR) Integration May Improve Patient Safety and Nursing Bedside Productivity
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced data in collaboration with The University of Texas ...
Scrooge: 5 Stocks That Could Ruin Your Santa Rally
Investors are hoping for a Santa Rally — the seasonal year-end surge that has historically delivered positive returns. Although macro conditions - including rate cuts and easing inflation - are suppor...
BAX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Baxter to Contact Him Directly to Discuss Their Options If you purchased or acquired ...
Macquarie Value Fund Q3 2025 Sales And Purchases
During 3Q, there were four full-position sales and purchases in Macquarie Value Fund. We sold our position in Conagra Brands Inc. (CAG), a leading food company with a broad array of well-known brands....
Bragar Eagel & Squire, P.C. Reminds James Hardie and Baxter International Investors to Contact the Firm Regarding Their Rights
NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stoc...
Baxter Announces Pricing of Tender Offers for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the consideration payable in connection with the previously announced cash tender off...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options
Baxter Announces Early Tender Results for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the early tender results for the previously announced cash tender offers for the 2026...
Baxter International Inc. (BAX) Presents at Evercore 8th Annual Healthcare Conference Transcript
Baxter International Inc. (BAX) Presents at Evercore 8th Annual Healthcare Conference Transcript
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options If you purchased or acquired ...
Artisan Value Income Fund Q3 2025 Contributors And Detractors
In the Core Value category, our biggest detractors were Baxter International (BAX) and Philip Morris International (PM). Another decliner was Kerry (KRYAY), the largest food and beverage ingredients c...
Baxter Announces Increase in Maximum Tender Cap for 1.915% Senior Notes Due 2027
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced that it has increased the maximum purchase price for its $1.45 billion aggregate prin...
Baxter Announces Tender Offers for 2026 Notes and 2027 Notes
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the commencement of tender offers, subject to the terms and conditions described belo...
Baxter International Inc. (BAX) Presents at Jefferies London Healthcare Conference 2025 Transcript
Baxter International Inc. ( BAX) Jefferies London Healthcare Conference 2025 November 18, 2025 8:00 AM EST Company Participants Kevin Moran - Vice President & Head of Investor Relations Joel Grade - ...
Greenhaven Bets Over $143 Million on a Turnaround at Medical Devices Leader Baxter
Greenhaven bought 6,288,349 shares for an estimated $143.19 million based on quarterly average pricing. Transaction equates to 2.77% of Greenhaven's 13F reportable assets under management.
Baxter Declares Quarterly Dividend
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.01 per share o...
BAXTER INTERNATIONAL INC. (NYSE: BAX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Baxter International Inc. Investors of Upcoming Deadline
NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Baxter International Inc. (NYSE: BAX)? Did you purchase your shares between February 23, 2022 and ...
The Baxter Foundation Announces $2.6M Grant to Advance STEM Education in Chicagoland Through Partnership With Northwestern University
DEERFIELD, Ill.--(BUSINESS WIRE)--The Baxter Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the continuation of a partnership with ...
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in Baxter International, Inc. Lawsuit – BAX
NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. (NYSE: BAX). Shareholders who purchased shares of BAX during th...
Watch These Stocks Falling 10% Or More
Fiserv (FI) leads decliners with a 49% drop, driven by leadership turmoil, weak consumer spending, and a downgraded quant rating to 'Strong Sell.' Alexandria Real Estate (ARE) and Robert Half (RHI) su...
Don't Write Off Baxter Just Yet
Baxter International (BAX) trades at a 20-year low after operational missteps, a failed Hill-Rom acquisition, and ongoing execution issues. Despite recent setbacks, BAX still generates solid margins a...
Why Baxter International Stock Dived by Nearly 15% Today
Its third-quarter performance didn't impress market players. Although net sales rose year over year, adjusted profitability declined at a double-digit percentage rate.
Baxter Trims Annual Outlook Again, Stock Hits 52-Week
Baxter International Inc. (NYSE:BAX) stock hit a 52-week low on Thursday, after the company again lowered its 2025 guidance.
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options